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CNF1 Exploits the Ubiquitin-Proteasome
Machinery to Restrict Rho GTPase Activation
for Bacterial Host Cell Invasion
domain (Lemichez et al., 1997). The enzymatic domain,
localized at the carboxy-terminal end, is translocated
into the cytosol, where it activates Rho GTPases (Pei et
al., 2001). CNF1 catalyzes a deamidation reaction, which
specifically modifies glutamine 63 of RhoA or its equiva-
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the critical deamidase catalytic residues are locatedCentre Antoine Lacassagne
33 avenue de Valombrose (Buetow et al., 2001). CNF1 target specificity is deter-
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Rho small GTPases were first characterized as regula-1919 route de Mende
34293 Montpellier tors of the actin cytoskeleton (Chardin et al., 1989; Pater-
son et al., 1990; Hall, 1998). Their signaling activitiesFrance
have since been extended to a large variety of cellular
processes, including the crosstalk between bacteria and
their hosts. Consistent with this, an increasing numberSummary
of microbial virulence factors and toxins have been
found to interfere with Rho GTPases (Boquet et al., 1998;CNF1 toxin is a virulence factor produced by uropatho-
genic Escherichia coli. Upon cell binding and introduc- Stebbins and Gala´n, 2001). Most bacterial toxins target
Rho GTPases to induce their inactivation. Surprisingly,tion into the cytosol, CNF1 deamidates glutamine 63
of RhoA (or 61 of Rac and Cdc42), rendering constitu- CNF1 and the related dermonecrotic toxin (DNT) from
Bordetella have opposite effects (Boquet, 2001; Hori-tively active these GTPases. Unexpectedly, we mea-
sured in bladder cells a transient CNF1-induced acti- guchi, 2001). The gain of function conferred by CNF1 to
Rho GTPases remains therefore to be elucidated.vation of Rho GTPases, maximal for Rac. Deactivation
of Rac correlated with the increased susceptibility of In the present study, we have investigated the extent
of Rho GTPase activation by the uropathogenic E. coliits deamidated form to ubiquitin/proteasome-medi-
ated degradation. Sensitivity to ubiquitylation could CNF1 toxin in the context of bladder epithelial cells.
This allowed us to demonstrate that CNF1 exploits thebe generalized to other permanent-activated forms of
Rac and to its sustained activation by Dbl. Degradation ubiquitin-proteasome machinery to confer invasive
properties to uropathogenic E. coli.of the toxin-activated Rac allowed both host cell motil-
ity and efficient cell invasion by uropathogenic bacte-
ria. CNF1 toxicity thus results from a restricted activa- Results
tion of Rho GTPases through hijacking the host cell
proteasomal machinery. CNF1 Induces a Transient Activation
of Rho GTPases
Introduction Owing to the relationship established between CNF1-
and UPEC-borne infections, we investigated the in vivo
The CNF1 toxin is a virulence factor produced by uro- effects of the toxin using the 804G-rat bladder carci-
pathogenic Escherichia coli (UPEC) strains, responsible noma cell line. The use of activated Rho GTPase pull-
for urinary tract infections (Blanco et al., 1992; Landraud down assays enabled us to quantify the levels of CNF1-
et al., 2000). CNF1 is also associated with other extrain- induced Rho GTPase activation, although it did not allow
testinal pathogenic E. coli such as those of serotype K1 us to differentiate between wild-type and deamidated
implicated in neonatal meningitis (Bonacorsi et al., 2000; active forms of Rho (Manser et al., 1998; Ren et al.,
Khan et al., 2002). More recently, a CNF1-like toxin has 1999). Nevertheless, pull-down assays offered us an
been found in Yersinia pseudotuberculosis (Lockman et approach to investigate the relationships between the
al., 2002). cellular effects of CNF1 and the level of activation of
Currently, CNF1 is the paradigm of the Rho GTPase- each Rho GTPase. Cells were treated with CNF1 and
activating bacterial toxins (Boquet, 2001). The amino- subjected to pull-down assays after different periods of
terminal part of the toxin contains the receptor binding time (Figure 1A). These experiments revealed two new
findings. We observed that CNF1 induced a transient
activation of Rac, RhoA, and Cdc42, instead of their5 Correspondence: lemichez@hermes.unice.fr
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Figure 1. CNF1 Induces a Transient Activa-
tion of Rho GTPases
(A) Immunoblots showing the kinetics of
CNF1-induced activation of Rho GTPases in
804G cells. Cells were treated with 109 M
CNF1 for different periods of time. Cell lysates
were subjected to the GST-fusion protein
pull-down assays. Activated Rho GTPases
bound to the GST-fusion proteins were re-
solved on SDS-PAGE and transferred on ny-
lon membranes for immunoblotting. Two per-
cent of the total CNF1-untreated lysate was
loaded on the same gel to estimate the
amount of cellular Rho GTPases engaged in
the assay. In parallel, 10 g of each cell lysate
were processed for actin immunoblotting to
verify protein amounts.
(B) Quantification of activated Rho GTPases.
Immunoblots were scanned and quantified
using NIH Image 1.6. The level of activated
Rho GTPases was compared to the total Rho
GTPase level present in 2% of the control cell
lysate (CNF1-untreated) (mean value of three
independent experiments  SD).
(C) 804G cells were treated with 109 M CNF1
for different periods of time. Cells were pro-
cessed for Rac immunolocalization together
with actin cytoskeleton labeling, as described
in the Experimental Procedures. From left to
right, the first column corresponds to the light
transmission pictures showing the effect of
CNF1 on cell morphology. The second and
third columns show the actin cytoskeleton
and the Rac immunosignal, respectively. The
bars equal 10 m.
expected permanent activation. Rac activation ap- of activated and downregulated forms of Rac (Figure
1C). Filamentous actin was labeled together with Rac.peared more transient as compared to that of RhoA and
Cdc42. We also observed that CNF1 induced a maximal Immunofluorescence signals were analyzed, using con-
focal microscopy conditions, which allowed us to com-level of activated-Rac and Cdc42, in contrast to RhoA
(Figure 1B). We further analyzed the effects of CNF1 on pare signal intensities. The 804G control cells displayed
mostly filopodia at their periphery. In such conditions,the actin cytoskeleton and cell morphology. We took
advantage of the ability of Rho GTPases to be recruited the Rac immunosignal appeared cytosolic together with
a fraction associated with endomembranes formingon cellular endomembranes upon activation to investi-
gate, by immunofluorescence, the behavior of Rac, perinuclear vesicles. After 1 hr of intoxication with CNF1,
cells displayed a strong spreading, as visualized by lightwhich antibody gives a strong immunosignal in contrast
to that from RhoA and Cdc42. Intoxicated cells were transmission microscopy. Spreading was followed by
cell retraction after 4 hr of CNF1 treatment. During theanalyzed at different time periods, according to the
pull-down measurements, to visualize the localization first 4 hr of CNF1 treatment, cells displayed a higher
CNF1-Induced Rho GTPase Ubiquitylation
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Figure 2. Kinetics and Specificity of CNF1-
Induced Rho GTPase Depletion
(A) Immunoblots showing the kinetics of
CNF1-induced Rho GTPases depletion. 804G
cells were treated for different times with 109
M CNF1. Cells were lysed in Laemmli buffer
and immunoblots performed using 30 g of
total protein lysate. Immunoblots anti-actin
were used to verify equal loading and normal-
ize Rho GTPase signals.
(B) Quantification of the CNF1-induced Rho
GTPase depletion (mean value of two inde-
pendent experiments  SD).
(C) Sequences of the Ras-related proteins
studied for CNF1 sensitivity were aligned in
the region surrounding the CNF1-deamidated
glutamine 61 of Rac1 and Cdc42 or 63 of
RhoA. Asterisk indicates RhoA arginine 68,
which confers the specificity of Rho GTPase
recognition by CNF1.
(D) Immunoblots showing the stability of
other Ras-related GTPases during CNF1 in-
toxication. Cell intoxication and immunoblots
were performed as described above.
(E) CNF1-induced Rac depletion is reverted
upon toxin clearing. After 4 hr of intoxication
with 109 M CNF1, 804G cells were exten-
sively washed in PBS and further incubated
in toxin-free medium. Cells were processed
at different times for Rac immunoblotting as
described above.
(F) Effect of the expression of CNF1 deami-
dase domain on Rac-induced cell depletion.
804G cells were transfected with either GFP
or GFP-CDDC866 (wild-type deamidase do-
main) or GFP-CDDC866A (inactivated deami-
dase domain). After 6 hr of transgene expres-
sion, Rac depletion was estimated by
immunoblotting, and equal expression of
GFP-CDD constructs was verified by anti-
GFP immunoblotting.
content of filamentous actin. In parallel, we observed a subfamily, we investigated the stability of other small
GTPases. In this respect, Ras, Ral, and Rap, which dopartial relocalization of Rac from the cytosol to the
plasma membrane and perinuclear vesicles. Most re- not contain the specific amino acid sequence necessary
to CNF1-mediated deamidation, were controlled formarkably, after 24 hr of continuous intoxication by CNF1,
cells exhibited a dramatic decrease of Rac immunosig- their toxin-induced cell depletion (Figure 2C; Lerm et
al., 1999b; Flatau et al., 2000). In contrast to Rhonal. These results suggested that the transient activation
of Rac induced by the toxin might have resulted from a GTPases, Ras, Ral, and Rap remained stable during
CNF1 treatment (Figure 2D).cellular depletion of this GTPase. Transient recruitment
of Rho GTPases to cellular membranes was confirmed Considering that Rac exhibited the most transient and
pronounced activation after cell intoxication, we fo-by cellular fractionation (not shown).
cused on this small G protein in the following experi-
ments. When CNF1 was provided to cells for 4 hr andCNF1 Induces the Specific Depletion
of Rho GTPases then removed, we observed that the Rac immunosignal
reappeared, indicating that the CNF1-induced depletionThe cellular content of Rho GTPases was analyzed by
immunoblotting (Figure 2A). The loss of Rho GTPases of Rac was a reversible process (Figure 2E). This latter
finding, together with our observation showing the sta-was almost complete after 24 hr of CNF1 treatment
(Figure 2A). The decrease was more dramatic for Rac, bility of Ras, Ral, and Rap, suggested that Rac depletion
was not the result of a nonspecific CNF1-induced toxic-as compared to RhoA and Cdc42 (Figure 2B). The initial
speed of clearance, measured between 30 and 90 min ity, but rather a consequence of the toxin-induced Rho
GTPase modification. This led us to examine whetherafter intoxication, was maximal for RhoA (aRhoA 0.50%/
min) when compared to that of Cdc42 and Rac (aCdc42  the CNF1 deamidase activity on Rac glutamine 61 might
be specifically required to induce the GTPase depletion.0.21%/min and aRac 0.15%/min, respectively). Notably,
the Rho GDP-dissociating inhibitor (RhoGDI) protein We addressed this question by expressing in cells the
minimum carboxy-terminal deamidating domain of thelevel remained stable during CNF1 intoxication (Figure
2A). To investigate whether CNF1-induced Rho GTPase toxin (CDD), nonmodified or mutated in its catalytic cys-
teine 866 (Buetow et al., 2001). GFP-fusion proteins cor-depletion was restricted to this particular Ras GTPase
Cell
556
Figure 3. CNF1-Induced Rac Ubiquitylation and Proteasomal Degradation
(A) Comparison of Rac half-life in the presence or absence of CNF1, in 804G cells. Cells were pretreated 10 min with 10 g·ml1 cycloheximide
(cyclo) followed by intoxication with 109 M CNF1 in the presence (cycloCNF) or absence of cycloheximide (CNF). The protein synthesis
blocking effect of cycloheximide was verified by incorporation of L-[U-14C]leucine (not shown). Cells were lysed in Laemmli buffer and
endogenous Rac signal was quantified by immunoblot, normalized to actin immunosignal (mean value of three independent experiments 
SD).
(B) Stability of Rac mRNA during CNF1 intoxication of 804G cells. Northern blotting was performed using pXJ-Rac as a probe. Total RNA
loading was visualized by 18S ribosomal RNA ethidium bromide staining.
(C) Immunoblots anti-Rac showing the blocking effects of proteasome inhibitors on the CNF1-induced Rac depletion. 804G cells were pretreated
CNF1-Induced Rho GTPase Ubiquitylation
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responding to the CDD wild-type (GFP-CDDC866) or mu- Rac in CNF1-treated cells was increased upon cotreat-
ment with LLnL proteasome inhibitor (Figure 3E). Thistated (GFP-CDDC866A) were expressed in 804G cells. A
30% depletion of Rac was found only in the GFP- indicated that proteasome inhibitors were most proba-
bly acting by blocking the degradation of the pool ofCDDC866-expressing cells, a percentage similar to the
transfection efficiency (Figure 2F). This indicated that activated Rac. We therefore concluded that the protea-
some machinery might be involved in the CNF1-inducedthe deamidase activity of CNF1 was required and suffi-
cient to mediate Rac depletion. clearance of Rac. Many short-living proteins are tagged
by addition of an ubiquitin chain directing their specific
degradation by the proteasome (Hershko and Ciec-CNF1 Induces Rac Ubiquitylation
and Proteasome-Dependent Depletion hanover, 1998). To investigate the possibility of a CNF1-
induced Rac ubiquitylation, we compared the amountThe fact that CNF1 induced a posttranslational modifica-
tion restricted to Rho GTPases led us to investigate the of endogenous ubiquitylated Rac under different condi-
tions. Histidine-tagged ubiquitin-transfected cells werepossible involvement of a degradative mechanism for
the toxin-induced Rac depletion. In contrast to control treated either with MG132 alone or together with CNF1.
We observed that treatment of cells with CNF1 inducedcells, in which Rac appeared to be a stable protein
(Figure 3A), we observed a decrease of Rac stability in a 2.3-fold greater appearance of Rac ubiquitylated forms
(Rac-Ubn), as compared to control cells (Figure 3F). InCNF1-treated cells (half-life 115 min). The fact that both
Rac stability and CNF1-induced Rac depletion half-lives addition, we observed a reduction of the ubiquitylated
level of cotransfected HA-Rac using the ubiquitin mutantwere found to match closely ruled out a possible inhibi-
tion of Rac translation induced by the toxin (Figure 3A). K48R, known to impair ubiquitin chain formation for pro-
teasome targeting (Figure 3G; Chau et al., 1989). WeThat CNF1 did not affect the Rac mRNA levels was also
verified (Figure 3B). Determination of the degradative have therefore established that CNF1 elicited an in-
crease of Rac ubiquitylation, likely responsible for itsmachinery responsible for Rac depletion was investi-
gated first using different cell-permeant protease inhibi- CNF1-induced proteasome degradation.
tors. Z-VAD, a blocker of caspase proteases, and three
different proteasome/calpain protease inhibitors, among Ubiquitin Modification of Rac Results from Its
Sustained Activationwhich lactacystin is the most specific for the protea-
some, were tested. At the concentrations used, only Our results raised the question of whether CNF1-
induced degradation of Rac was a consequence of itsproteasome inhibitors conferred a significant protection
against CNF1-induced Rac depletion (Figure 3C). To sole mutation or was due to its permanent activation.
To discriminate between these possibilities, the steady-rule out a possible inhibition of the CNF1-induced Rho
GTPase deamidation/activation by proteasome inhibi- state levels of three permanently activated Rac mutants
(Rac-Q61L, Rac-Q61E, and Rac-G12V) were comparedtors, we monitored the effects of CNF1 on the actin
cytoskeleton and cell morphology (Figure 3D). The treat- to that of dominant-inactive Rac-T17N and Rac wild-
type. Cells were transfected with both Rac mutants andment of cells with CNF1 for 6 hr induced the formation
of filopodia (Figures 3D and 1C). Furthermore, cells did GFP expression plasmids to normalize the amounts of
proteins expressed. We observed that all three activatednot exhibit a higher content of F actin when compared
to a control preparation. In contrast, upon addition of mutants were less stable than the wild-type and domi-
nant-negative Rac proteins (Figure 4A). To investigateproteasome inhibitors during the CNF1 treatment, cells
displayed a strong spreading together with an increased whether the instability of the Rac dominant-positive mu-
tants depended on the proteasomal machinery, we com-content of filamentous actin (Figure 3D). This indicated
that proteasome inhibitors interfered with, rather than pared their ubiquitylation sensitivity. Rac-Q61E exhib-
ited a 3-fold higher sensitivity to ubiquitylation than theinhibited, the CNF1 effects on the cell cytoskeleton. We
next tested the possibility that proteasome inhibitors wild-type Rac, in accordance with the 2.3-fold induction
of endogenous-Rac ubiquitylation measured in CNF1-might in fact increase the level of activated Rac upon
CNF1 treatment. We observed that the level of activated intoxicated cells (Figures 4B and 3F). In addition, all
with the different protease inhibitors (20 M Z-VAD, 50 M LLnL, 10 M MG132, and 20 M Lactacystin) for 30 min before addition of 109
M CNF1. Upon 3 hr of CNF1 intoxication, cells were lysed in Laemmli buffer and processed for anti-Rac immunoblotting using 20 g of total
proteins. Cells treated with the drugs alone did not show changes in their total Rac content.
(D) FITC-phalloidin labeling of the actin cytoskeleton showing CNF1 effects on cell spreading and actin bundling in the presence of proteasome
inhibitors. After 6 hr of 804G cells treatment with or without 109 M CNF1, in the presence or absence of protease inhibitors, the cells were
labeled with FITC-phalloidin to visualize the actin cytoskeleton (the bars equal 10 m).
(E) Addition of 50 M LLnL proteasome inhibitor reinforces the CNF1-induced activation of Rac. After 6 hr of treatment, cells were processed
for Rac GST-PAK70-106 pull-down assay. The amount of proteins engaged in the pull-down assay was verified by actin immunoblotting (top).
(F) CNF1 intoxication of 804G cells results in an increase of Rac ubiquitylation. Cells expressing Histidine-tagged ubiquitin (His-Ub) were
treated with 10 M MG132 with or without 108 M CNF1 for 4 hr and processed for histidine-tagged ubiquitin purification (107 transfected
cells for each condition). His-Ub crosslinked forms of endogenous Rac (noted Rac-Ubn) were visualized by immunoblotting anti-Rac. An anti-
Rac immunoblot was performed in parallel on 1% of the total lysates to compare the amounts of total Rac engaged in the His-Ub purifications
(bottom).
(G) 804G cells expressing HA-tagged wild-type Rac and/or Histidine-tagged ubiquitin wild-type (His-Ub WT) or K48R mutant (His-Ub K48R)
were treated 15 hr with 108 M CNF1 and processed for histidine-tagged ubiquitin purification. His-Ub crosslinked forms of HA-Rac were
visualized by immunoblotting anti-HA (noted HA-Rac-Ubn). An anti-HA immunoblot was performed in parallel on 1% of the total lysates to
compare the amounts of total HA-Rac engaged in the His-Ub purifications (bottom).
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Figure 4. Activated Rac Mutants Are Highly
Sensitive to Ubiquitylation
(A) Stability of Rac mutants in 804G cells.
Cells were cotransfected with both 1 g of
GFP and 2 g of HA-Rac mutants expressing
plasmids. Equal amounts of total lysates were
resolved on 12% SDS-PAGE and immu-
noblotted with anti-HA and anti-GFP. Side
graph: Quantification of Rac mutants stability
was assessed by calculating the ratio be-
tween HA-Rac mutant protein levels and the
respective GFP protein levels. A factor 1 sta-
bility was arbitrarily set for wild-type Rac
(mean value of three independent experi-
ments  SD).
(B) His-Ub purification followed by anti-HA
immunoblotting showing the Rac mutants
ubiquitylation level in 804G cells. Transfected
cells expressing His-tagged ubiquitin to-
gether with dominant-active forms of Rac
mutants (HA-Rac-Q61E, -Q61L, or -G12V),
wild-type (WT), or a dominant-inactive form
(HA-Rac-T17N) were purified for histidine-
tagged ubiquitylated-Rac and processed for
HA-Rac immunoblotting. The HA-immu-
noblot in the lower gel shows the levels of
transfected HA-Rac used. Side graph: Quan-
tification of Rac mutant ubiquitylation effi-
ciencies corresponding to the ratio of poly-
ubiquitylated Rac (Rac-Ubn) to total Rac
(mean value of three independent experi-
ments  SD).
(C) Measure of Rac activation. HA-Rac wild-
type and mutants were expressed for 12 hr
in 804G cells, together with Dbl495–826 (referred
to as Dbl) when indicated. Rac activation was
assessed by pull-down assay. The graph
shows the quantification of the activated Rac
levels. A 100% value was arbitrarily set for
Rac-Q61L (mean value of three independent
experiments  SD).
(D) Comparison of the ubiquitylation efficien-
cies between HA-Rac-Q61L, HA-Rac-T35A,
HA-Rac-Q61L-T35A, and wild-type HA-Rac
(Dbl495–826), as described in (B).
three dominant-positive forms of Rac appeared more 2-fold increased sensitivity of Rac ubiquitylation (Figure
4C). The low level of Dbl-induced Rac ubiquitylationsusceptible to ubiquitylation with regard to both domi-
nant-negative and wild-type Rac (Figure 4B). Rac mutant perfectly correlated with the limited stimulation potency
of Dbl, as compared to activating mutations of Rac (Fig-ubiquitylation sensitivity appeared to be a function of
the strength of their respective activating mutation (Fig- ure 4D). Studying CNF1, we could unravel that sustained
activation of Rac sensitizes it to ubiquitylation. Thisure 4C). Specificity of activated Rac ubiquitylation was
further investigated by mutating the threonine 35 of Rac, prompted us to investigate whether CNF1 had exploited
this downregulation of Rac to confer virulence proper-a mutation that was shown to impair the Ras switch
transition required for effectors binding (Spoerner et al., ties to pathogenic bacteria.
2001). As predicted from the above observations, muta-
tion of threonine 35 reversed the ubiquitylation sensitiv- Proteasome Depletion of CNF1-Activated Rho
GTPases Induces Cell Motilityity of Rac-Q61L (Figure 4D). Finally, we measured that
the sustained activation of Rac, using Dbl495-826 exchange We further analyzed the toxin-induced cellular morpho-
logical changes by time-lapse videomicroscopy duringfactor (Olson et al., 1996), resulted in a reproducible
CNF1-Induced Rho GTPase Ubiquitylation
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Figure 5. CNF1 Induces Cell Motility
(A) Visualization at four different timings of 804G cells intoxicated by 109 M CNF1, selected from Supplemental Video S1 at http://www.cell.com/
cgi/content/full/111/4/553/DC1. This video documents the cell spreading during the first 60 min of intoxication (recorded at 1 frame/30 s and
played at 1 frame per 1/30 s).
(B) Visualization of 109 M CNF1-intoxicated cells at eight different timings selected from Supplemental Videos S3 and S4 (recorded at 1
frame/30 s, using a 20 lens and played at 1 frame per 1/30 s). Supplemental Videos S3 and S4 document the sustained cell spreading during
the first 4 hr, followed by the CNF1-induced cell motility. Supplemental Videos S1, S3, and S4 were recorded on the same field, using a 20
lens.
(C) Sequence of pictures, selected from Supplemental Video S7, showing the disruption of cellular junctions induced upon 6 hr of cells
intoxication by 109 M CNF1 (recorded at 1 frame/60 s using a 40 lens and played at 1 frame per 1/30 s).
(D) Addition of proteasome inhibitor results in a blocking effect on the CNF1-induced cellular junctions dynamic and cell motility. Pictures
depict three times selected from Supplemental Video S8. This video was recorded during 4 hr of cell intoxication starting after 2 hr addition
of 109 M CNF1 and 20 M lactacystin (recorded at 1 frame/60 s, using a 40 lens and played at 1 frame per 1/30 s). The bars equal 10 m.
Cell
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Figure 6. Overexpression of Rac Blocks CNF1-Induced Cell Motility
(A) Immunoblot anti-Rac1 showing the persistence of the HA-Rac signal in wild-type HA-Rac expressing 804G cells treated for different time
periods with 109 M CNF1 alone or in combination with cycloheximide.
(B) Wild-type Rac overexpression inhibits the toxin-induced cell motility. Pictures were selected from Supplemental Videos S9 (GFP  Rac)
and S10 (GFP alone). Supplemental Video S9 was performed from 3 to 9 hr after addition of 109 M CNF1 to 804G cells coexpressing wild-
type Rac and GFP. Supplemental Video S10 was performed from 2 to 14 hr after addition of 109 M CNF1 to 804G cells expressing GFP
alone. Both videos were recorded at 1 frame/30 s, using a 20 lens and played at 1 frame per 1/30 s.
the period corresponding to the previously measured 5B and Supplemental Video S4). Moving cells displayed
a classical pattern of polarity (Ridley, 2001), althoughkinetics of Rho GTPases activation and deactivation
(Figure 1A). Figure 5 presents samples of pictures se- cells migrated in random patterns, frequently changing
their direction (Supplemental Video S4). In addition, welected from the different videos. During the first hour of
intoxication, corresponding to the Rho GTPases activa- observed in primary HUVEC endothelial cells, a cellular
model for K1 E. coli producing CNF1, a toxin-inducedtion phase, cells underwent a strong spreading (Figure
5A and see Supplemental Video S1 at http://www.cell. cellular motility starting 6 hr after intoxication and requir-
ing the functional deamidase domain of the toxin (seecom/cgi/content/full/111/4/553/DC1). We verified that
heat-inactivated CNF1 did not induce such a cell pheno- Supplemental Videos S5 and S6, respectively). Follow-
ing 804G cells spreading, during the raising of cell motil-type (Supplemental Video S2). Spreading was followed
by a period of intense membrane ruffling, from 1 to 4 ity, we observed that cellular contacts were highly dy-
namic, constantly forming and dislocating (Figure 5Chr, corresponding to the maximum activation of the Rho
GTPases (Figure 5B and Supplemental Video S3). At 4 and Supplemental Video S7). Together, our observations
pointed out the role of the proteasomal machinery inhr of intoxication, while proteasome activity started to
reduce the level of activated Rho GTPases, membrane controlling the level of CNF1-induced Rho GTPase acti-
vation, resulting in cell motility during Rho GTPaselamellipodia were progressively replaced by filopodia-
like structures (Figure 5B and Supplemental Video S3). depletion. Consistent with this, we observed that co-
treatment with lactacystin during cell intoxication re-This process was accompanied by the induction of frank
cell motility, 6 hr after intoxication up to 24 hr (Figure sulted in a sustained cell spreading and had a blocking
CNF1-Induced Rho GTPase Ubiquitylation
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Figure 7. CNF1-Induced Uropathogenic Bac-
teria Internalization
(A) Southern blotting showing the presence
or absence of Tn5 either in pBR322-Tn5TC1
plasmid or 58A1 conjugated and parental J96
genomic DNA. Genomic DNA was digested
with BamH1 (outside Tn5) and probed with
a Tn5TC1 0.6 kb EcoR1-Xba1 fragment, as
described in the Experimental Procedures.
(B) DNA ethidium bromide staining of PCR
amplification products of both cnf1-cter and
-nter domain coding sequences performed
on J96, 58A1, and XL1-blue genomic DNA.
(C) CNF1-induced 58A1 cell internalization.
Monolayers treated for different times with
109 M CNF1, alone or with lactacystin when
indicated (6L), were proceeded for bacterial
infection followed by gentamicin protection
assay, as described in the Experimental Pro-
cedures. Values on the y axis represent the
relative percent of intracellular bacteria, as
compared to cell-associated bacteria (mean
value of three independent experiments per-
formed in duplicate  SD).
(D) CNF1-induced 58A1 cell internalization in
804G cells expressing permanently activated
Rac mutants. Values on the y axis represent
the relative percent of intracellular bacteria,
as compared to cell-associated bacteria
(mean value of three independent experi-
ments performed in duplicate  SD).
effect on both cellular junction dynamics and cell motility 7B). We verified the requirement of CNF1 for uropatho-
(Figure 5D and Supplemental Video S8). The requirement genic bacteria cell invasion, as previously described for
of Rac degradation in allowing cell motility was further K1 E. coli (Khan et al., 2002; see Supplemental Figure
investigated, compensating for its degradation by wild- S1 at http://www.cell.com/cgi/content/full/111/4/553/
type Rac overexpression (Figure 6A). As hypothesized DC1). Comparison of Rho GTPase activation and degra-
from the blocking effect of lactacystin, forced expres- dation phases in allowing bacterial invasion was tested
sion of Rac impaired the toxin-induced cell motility (Fig- by intoxication of 804G cells for different times prior to
ure 6B and Supplemental Videos S9 and S10). addition of 58A1 bacteria. Addition of CNF1 to cells
CNF1 producing gram-negative bacteria live in close appeared to be strictly required to allow bacteria inter-
contact with epithelial cell layers. This led us to investi- nalization by nonphagocytic uroepithelial cells (Figure
gate the effect of CNF1 on uroepithelial cell monolayers. 7C). Interestingly, the efficiency of bacteria internaliza-
Addition of CNF1 induced a sequence of cell-shape reor- tion started to increase during the Rho GTPase deactiva-
ganization, similar to that of isolated cells and resulting tion phase (around 4 hr of intoxication) (Figure 7C). That
in the raising of cell motility inside the monolayer (see bacteria maximal internalization required both Rho
Supplemental Video S11 at http://www.cell.com/cgi/ GTPase activation and degradation (i.e., Rho GTPases
content/full/111/4/553/DC1). Moreover, we observed restricted activation) was also supported by the obser-
that the cell motility inside the monolayer remained in- vation that at 24 hr CNF1 intoxication, cells remained
tense after a long period of intoxication, some cells highly competent for bacteria internalization. In agree-
seeping underneath each other (Supplemental Video ment with the fact that activated Rho GTPase degrada-
S12). We also verified that heat-inactivated CNF1 did tion was required for efficient bacterial invasion, addition
not induce cell movements (Supplemental Video S13). of lactacystin (which does not interfere with bacteria
Together, our observations demonstrate that CNF1 pro- growth and viability) considerably reduced cell invasion
voked cell motility and cellular junction dynamics upon (Figure 7C). Implication of Rho GTPase degradation was
reduction of the activated Rac GTPase cellular level. further demonstrated using 804G cells expressing per-
manently activated Rac mutants (Figure 7D). With regard
to pcDNA3-transfected cells, we observed that acti-Rho GTPase Activation and Degradation Allow
vated Rac mutants expression reduced bacteria inter-Efficient Host Cell Invasion
nalization to the low level induced by mere Rac activa-We further tested the implication of both CNF1-induced
tion observed at 1 hr (Figure 7D). Together, our resultsRho GTPase activation and degradation phases for bac-
demonstrate that activation of Rac by CNF1 is requiredteria internalization into host cells. We generated a uro-
for initiating uropathogenic bacteria internalization bypathogenic J96 bacteria (Low et al., 1984; Blum et al.,
1995) knocked in cnf1, referred as 58A1 (Figures 7A and nonphagocytic uroepithelial cells and that Rac degrada-
Cell
562
tion, resulting in lowering the threshold of its activity, of Rac measured in primary endothelial HUVEC or in
804G cells (see Supplemental Figure S2 at http://confers higher bacterial invasive characteristics to in-
toxicated cells. www.cell.com/cgi/content/full/111/4/553/DC1). An-
other nonexclusive possibility would be that this mecha-
nism might contribute to Rnd proteins regulation, a fam-Discussion
ily of GTPase-deficient Rho-like proteins (Nobes et al.,
1998; Li et al., 2002).Using a bladder epithelial cell target model for CNF1, we
Concurrent with the proteasome-dependent reduc-could demonstrate that the bacterial toxin mechanism of
tion of the activated Rho GTPases cellular levels, intoxi-action consists in a restricted stimulation of Rho
cated cells started to produce membrane extensionsGTPases. This CNF1-induced restricted activation is a
and retractions associated with cell movement and cel-direct consequence of the cell-mediated degradation of
lular connection remodeling. Restricted activation ofthe toxin-activated forms of Rho GTPases. Degradation
Rho GTPases by the toxin appeared to be sufficient torequires the proteasome machinery. More generally, we
control the basic machinery necessary for cell move-could demonstrate that the sustained activation of Rac
ments. Consistent with our model, we could block theresulted in its sensitization to ubiquitylation and protea-
CNF1-induced cell motility either by addition of lacta-some degradation. Restricted activation of Rac by the
cystin or Rac sustained expression. We could also ob-dual CNF1 molecular mechanism appeared to be re-
serve that in contrast to 804G cells and HUVEC cells,quired for the toxin-induced cellular motility and UPEC
sustained activation of Rac in HEp-2 cells resulted in aefficient internalization by bladder epithelial cells. Our
lack of cell motility (see Supplemental Video S14 atresults thus provide evidence that CNF1 might be a bona
http://www.cell.com/cgi/content/full/111/4/553/DC1).fide invasive factor that exploits the host proteasomal
Our observations raised the question of whether CNF1-machinery.
induced cell motility might contribute to bacteria coloni-Since the discovery that CNF1 induces a posttransla-
zation and/or epithelium invasion. One hypothesis couldtional modification of Rho GTPases, resulting in their in
be that upon attachment of the bacteria to the host cells,vitro permanent activation, it was assumed that such a
induction of cell streaming by the toxin might contributemodification provoked the sustained activation of Rho
to bacterial spreading at the surface of the epithelium,GTPases in host cells (Flatau et al., 1997; Schmidt et
thereby favoring the colonization of new territories. Inal., 1997). We provide in fact new evidence that host
addition to cell migration, cellular contact remodelingcell intoxication by CNF1 only induces a transient activa-
might contribute to pathogenic bacteria invasion oftion of Rho GTPases, giving a maximal level of activated
deeper parts of the epithelium.Rac and Cdc42. We have demonstrated that Rac is
The idea that degradation of Rho GTPases upon theirnormally a stable protein and that, upon modification
activation does not represent a host response to aby CNF1, Rac is ubiquitylated and degraded. Consistent
pathogen attack, but rather a response exploited bywith this, we observed that inhibition of the proteasomal
the pathogen, is strengthened by our observation thatmachinery allowed the recovery of higher levels of acti-
permanently activated Rac degradation allows not onlyvated Rac. Our results indicate that depletion of Rho
host cell motility but also confers higher invasive proper-GTPases by the proteasome resulted from the higher
ties to bacteria. These two features may contribute tokinetics of their deamidation and degradation not com-
the success of bacterial epithelium invasion, which ispensated by Rho GTPase synthesis.
important for urinary tract infection (Mulvey et al., 2000).The toxin-induced sensitivity of Rac to ubiquitylation
Interestingly, the pathogenic bacteria Salmonella deliv-and degradation could be generalized to other forms of
ers antagonistic Rho GTPase regulatory molecules,permanently activated Rac. We first observed that Rac
namely SopE and SptP. The SopE exchange factor activ-ubiquitylation efficiency correlated with the strength of
ity toward Rac and Cdc42 is responsible for their acti-the activating mutation, Q61L being the most sensitive
vation, whereas the SptP GAP activity provokes theirone. Second, we observed that the T35A mutation, lo-
inactivation, leading to the notion of a pathogen self-cated in the effector binding domain, reversed the ubi-
restricted response (Gala`n and Zhou, 2000). UPEC ex-quitylation sensitivity of Rac-Q61L. Finally, our observa-
pressing CNF1 may have thus developed a system fortion that a sustained activation of Rac, using Dbl, also
mimicking a GEF/GAP Rho GTPase limited activation,sensitized Rac to ubiquitylation proportional to its acti-
resulting in host cell invasion and motility.vation level eliminated a possible degradation of Rac
Pathogenic bacteria-induced host cell internalizationdue to mere protein misfolding. Depletion of Rho
is a hallmark of invasion and sepsis. In view of the CNF1GTPases by CNF1 required several hours. This mecha-
mechanism of action, further work should elucidate bothnism obviously cannot be used by cells to rapidly down-
CNF1 implication in E. coli-induced meningitis and re-regulate a stimulation of Rho GTPases, for instance by
current cystitis. We provide definitive evidence that effi-growth factors, and therefore does not substitute for
cient bacteria invasion is realized by limiting the thresh-Rho GTPase activating proteins (GAP). One possibility
old of Rac activation and that CNF1 has achieved thiswould be that this mechanism constitutes a vigilance
condition by exploiting the ability of cells to withdrawsystem elaborated by cells to counteract the nocuous
permanently activated Rho GTPases.effects of a permanent activation of Rho GTPases for
cell homeostasy. Consistent with this, we observed a
Experimental Procedureslower CNF1-induced degradation rate of Rac in some
carcinoma cells. This correlated to a 10-fold lower ca- Transfection, Materials, and Constructs
pacity of Rac ubiquitylation, for instance in HEp-2 larynx 804G rat bladder carcinoma cells were propagated in DMEM 10%
fetal bovine serum (GIBCO-BRL, Paisley, Scotland). Transfectionscarcinoma cells, as compared to the ubiquitylation rate
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were performed by electroporation, except for pEGFP-C2-CDD con- formed using the anti-Rac1 antibody described above and was visu-
structs, which were transfected using ExGen 500 (Euromedex, alized using Texas red-conjugated anti-mouse mAb (Vector, Bioval-
France) with 2 g of plasmid. Electroporations were performed as ley, Marne la Valle´e, France). Actin cytoskeleton was labeled using
follows: 5  106 cells were electroporated with 30 g of total DNA 1 g·ml1 FITC-conjugated phalloidin (Sigma). Immunosignals were
at 300V, 450 F. The efficiency was approximately 30% using both analyzed with a TCS-SP confocal microscope (Leica, Heidelberg,
methods, as assessed by epifluorescence microscopy of cells trans- Germany) using a 63 magnification lens. Each picture represents
fected with pEGFP-C2 (Clontech, Palo-Alto, CA). When indicated, the projection of eight serial confocal optical sections. In order to
cells were treated with the following inhibitors: Z-VAD, MG132, ALLN compare the Rac immunosignal intensities during the time course
(referred as LLnL), and Lactacystin (Calbiochem, CA). of CNF1 cell intoxication, we set up standard conditions of signal
Rac mutants were obtained using the QuickChange Site Directed acquisition for this GTPase on the 1 hr CNF1-treated cell sample.
Mutagenesis Kit (Stratagene Europe, The Netherlands) on pXJ-HA- We verified the absence of “bleed-through” for both signals. Cells
Rac wild-type (Manser et al., 1998), containing the polymorphism were filmed for different periods of time, in constant conditions of
I135T. HA-Rac mutants were obtained as follows: GAA for HA-Rac- 5% CO2 and 37C, and observed by phase-contrast optics using
Q61E, CTA for HA-Rac-Q61L, GTA for HA-Rac-G12V, GCC for HA- an Axiovert 200 microscope (Carl Zeiss, Go¨ttingen, Germany) with
Rac-T35A, and AAC for HA-Rac-T17N. The absence of other mutations shutter-controlled illumination (Carl Zeiss) and a cooled, digital CCD
was verified by sequencing the entire coding region. GFP-CDD con- camera (Roper Scientific) using a 40 or 20 lens, as indicated.
structs were obtained by PCR amplification of the CNF1 sequence Images were recorded at 1 frame/30–60 s depending on the condi-
encompassing amino acids 720–1014. The PCR fragment was sub- tions and processed using MetaMorph 2.0 image analysis software
cloned BamH1-EcoR1 in pEGFP-C2 (Clontech). GFP-CDDC866A was (Universal Imaging) and QuickTime pro 5 software (Apple).
obtained by QuickChange Site Directed Mutagenesis, converting
the coding sequence of cysteine 866 into GCT. Construction of J96 Knocked-in cnf1
CNF1 and CNF1C866S toxins were purified as described previously and 804G-Cell Monolayer Infection
(Flatau et al., 1997). The E. coli 58A1 strain, corresponding to J96 cnf1::Tn5, was ob-
Antibodies were purchased from Transduction Laboratories (anti- tained by standard conjugation of J96 with Bug 241 containing
Rac1, anti-Rho [raised against a sequence of RhoA highly homolo- pBR322-Tn5TC1 (Sasakawa and Yoshikawa, 1987). Conjugated
gous to RhoB and RhoC], anti-Cdc42, anti-RalA, anti-Rap1, and bacteria were screened for the absence of CNF1 expression using
anti-Ras), from Santa Cruz (anti-RhoGDI [clone A-20]), from BabCo a multinucleation assay with HEp-2 cells (Lemichez et al., 1997).
(anti-HA [clone 11]), from Sigma (St. Louis, MO) (anti- actin [clone Four strains of conjugated bacteria were isolated out of 3500. 58A1
AC-74]), and from Roche (Mannheim, Germany) (anti-GFP [clones was found to have a unique insertion of Tn5 by Southern blotting of
7.1 and 13.1]). Primary antibodies were visualized using goat anti-
genomic DNA digested BamH1, using a 0.6 kb EcoR1-Xba1 Tn5TC1
mouse or anti-rabbit horseradish peroxidase-conjugated secondary
probe and the dig high-prime DNA labeling and detection starter
antibodies (DAKO, Glostrup, Denmark) followed by chemilumines-
kit II (Roche). Tn5 insertion in the 58A1 cnf1 carboxy-terminal domain
cence detection (ECL, Amersham, Buckinghamshire, UK).
was assessed by PCR using the following primers (ATGGGTAAC
CAATGGCAAC and GCGTTTCTTAACAGAAATAGC for NTER ampli-
Activated Rho GTPase Pull-Down
fication and AGTATCGAAAGCACCTCCT and TCAAAATTTTTTTG
Pull-down assays were performed using 1 mg of cell lysate for Rho
AAAATACCTTC for CTER amplification). For bacterial infection
and Cdc42 or 0.5 mg for Rac, using 40 g of either GST-PAK70–106
assay, 4  105 uroepithelial cells were seeded per 35 mm well 24for Rac and Cdc42 or GST-Rhotekin RBD for Rho, as described
hr before infection. 10:1 exponentially growing 58A1 bacteria were(Manser et al., 1998; Ren et al., 1999). Two percent of the control
added to cell monolayers intoxicated with 109 M CNF1 for differentCNF1-untreated total lysate was loaded to estimate the Rho
periods of time supplemented with 20 M lactacystin if indicated.GTPases cellular content in order to quantify the ratio of CNF1-
Internalization was allowed during 15 min at 37C after 5 min centrifu-activated Rho GTPases. Proteins were resolved on 12% SDS-PAGE
gation at 1000 rpm. Infected monolayers were either washed threefollowed by transfer on PVDF membranes (Amersham, Saclay,
times and lysed for cell-associated bacteria measurement (aboutFrance). Activated Rho GTPases were revealed by immunoblotting
5% of total bacteria) or washed once and incubated 20 min with 50using monoclonal anti-Rho GTPases. In parallel, the equal amount
g·ml1 gentamicin before lysis for internalized bacteria measure-of proteins engaged in the pull-down assays was confirmed by
ments (Falkow et al., 1987). Cells were lysed in PBS, 0.1% tritonimmunoblotting anti--actin.
X-100 and bacteria were counted on LB ampicillin 100 g·ml1
plates. When indicated, 804G cells were transfected the day beforeMetal-Affinity Precipitation
by electroporation. The transfection efficiency based on Rac pheno-For endogenous Rac ubiquitylation measurements, cells were trans-
type was about 50%.fected by electroporation either with pRBG4-6HisUb or pRBG4-
6HisUbK48R (30 g/5  106 cells). Three hours after transfection,
Acknowledgmentscells were either untreated or treated 15 hr with 108 M CNF1, as
indicated, and lysed in ULB (8 M Urea, 20 mM Tris-HCl [pH 7.5],
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